A simple infection-control protocol to reduce serious cardiac device infections
Open Access
- 11 June 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 16 (10) , 1482-1489
Abstract
Device infection is a serious complication and is considered procedure-related if occurring within 12 months of an intervention. We analysed the effectiveness of a simple infection-control protocol (ICP) at reducing cardiac device infections (CDIs) in a tertiary referral centre. Prior to the introduction of a new ICP, we retrospectively analysed all simple and complex device implants, related procedures, and infections over a 3-year period. A new protocol was implemented from November 2007, including antibiotic prophylaxis determined by risk stratification, improved glycaemic control, specific skin preparation, and closure techniques, as well as different diathermy settings. Follow-up data for all patients were collected. Risk factors for infection were compared between pre- and post-intervention groups to ensure that the populations were comparable. A cost analysis of CDI and a review of the commonly identified micro-organisms were also undertaken. One thousand seven hundred and ninety-eight procedures were performed between November 2004 and November 2007 and 981 procedures between November 2007 and May 2009. There were no significant differences in the risk factors for infection between the two groups. Following the introduction of the ICP, there was a 54% reduction in the incidence of CDI from 1.3 to 0.6% (P < 0.03; CI 0.25, 1.36). Most patients with CDI had negative blood cultures or grew Staphylococcus sp. The average cost was £30 958.40 per infection incident and the cost of the new ICP was minimal. A significant reduction in CDI can be achieved with the introduction of a simple ICP with substantial cost savings.Keywords
This publication has 42 references indexed in Scilit:
- Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure EventsNew England Journal of Medicine, 2009
- Rising Rates of Cardiac Rhythm Management Device Infections in the United States: 1996 through 2003JACC, 2006
- Cardiac device infections: getting to the heart of the matterCurrent Opinion in Infectious Diseases, 2006
- Reasons for Escalating Pacemaker ImplantsThe American Journal of Cardiology, 2006
- Implantable Cardioverter-DefibrillatorsJAMA, 2006
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Local symptoms at the site of pacemaker implantation indicate latent systemic infectionHeart, 2004
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implantsThe American Journal of Cardiology, 2001